Development and Application of Portable Multisensory Stimulation Device

July 14, 2019 updated by: Buddhist Tzu Chi General Hospital

Development and Application of Portable Multisensory Stimulation Device: Vibroacustic Therapy

This is a study to develop the vibroacustic devices, and to compare the effects between vibroacustic device therapy and music therapy in adults with dementia or with neck pain. The immediate effect and long-term training effect would be assessed.

Study Overview

Status

Unknown

Intervention / Treatment

Detailed Description

The outcome measures included functional assessment ( such as: range of motion, balance etc.) and neurolphysiological assessment (such as: electroencephalographic activity or electromyographic activity).

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

19 years to 95 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • mild to moderate Dementia
  • age-matched healthy subjects

Exclusion Criteria:

  • can not follow order

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Comparison between unisensory and multisensory stimulation
The same person receive unisensory and multisensory stimulation on separate day.
the participants will receive the vibroacustic device or music therapy
EXPERIMENTAL: The treatment effect of multisensory stimulation
The persons living in long-term care facility would receive multisensory stimulation for one month.
the participants will receive the vibroacustic device or music therapy
EXPERIMENTAL: Multisensory stimulation and virtual reality.
The subjects would receive vibroacoustic therapy or virtual reality.
the participants will receive the vibroacustic device or music therapy
EXPERIMENTAL: Vibroacustic therapy on neck pain.
The subjects would receive either vibroacustic therapy or music therapy.
the participants will receive the vibroacustic device or music therapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
the electroencephalographic (EEG) activities ncluding Alpha, Beta, Theta, and Delta signals will be assessed in persons with mild to moderate dementia and healthy subjects.after sensory stimulation. .
Time Frame: one year
The EEG was recorded by EMOTIV EPOC+ mobile headset (Bioinformatics Company, USA). The wireless 14-EEG channels on the skull were located at anterior frontal (AF), frontal (F), frontal central (FC), temporal (T), parietal (P) and occipital (O) areas,The frequency analysis of brain waves includinh Alpha, Beta, Theta, and Delta signals before, during and after sensory stimulation will be recorded and analyzed.
one year

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The pressure pain threshold following multisensory stimulation will be assessed around cervical region.
Time Frame: one year
The pressure pain threshold was measured by MicroFET3 ( Hoggan Health Industries, Utah, USA) at cervical region including cervical erector (CE), upper trapezius (UT) and sternocleidomastoid (SCM). At the trigger point of the muscle, the pressure of the test group is increased at a rate of about 1 newton/second. When the subject feels uncomfortable, the active stop is the end point of the test for perceived pain threshold.
one year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Chich-Haung Yang, PhD, Tzu Chi University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 1, 2017

Primary Completion (ACTUAL)

July 1, 2019

Study Completion (ANTICIPATED)

July 1, 2019

Study Registration Dates

First Submitted

May 30, 2019

First Submitted That Met QC Criteria

June 28, 2019

First Posted (ACTUAL)

July 2, 2019

Study Record Updates

Last Update Posted (ACTUAL)

July 16, 2019

Last Update Submitted That Met QC Criteria

July 14, 2019

Last Verified

July 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • IRB105-116-A
  • 107-2218-E-320 -001 - (OTHER_GRANT: Ministry of science and technology)
  • 106-2218-E-320 -001 - (OTHER_GRANT: Ministry of science and technology)
  • IRB107-39-B (OTHER: Buddhist Tzu Chi Hospital)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cognitive Impairment

Clinical Trials on vibroacoustic device

3
Subscribe